Histone deacetylase 6 suppression protects from myocardial ischaemia-reperfusion injury in diabetes: insights from genetic deletion and pharmacological inhibition

Cardiovasc Res. 2024 Oct 14;120(12):1369-1371. doi: 10.1093/cvr/cvae145.
No abstract available

Publication types

  • Letter
  • Editorial
  • Comment

MeSH terms

  • Animals
  • Diabetes Mellitus, Experimental / complications
  • Diabetes Mellitus, Experimental / enzymology
  • Diabetes Mellitus, Experimental / genetics
  • Diabetes Mellitus, Experimental / metabolism
  • Histone Deacetylase 6* / antagonists & inhibitors
  • Histone Deacetylase 6* / genetics
  • Histone Deacetylase 6* / metabolism
  • Histone Deacetylase Inhibitors* / pharmacology
  • Histone Deacetylase Inhibitors* / therapeutic use
  • Mice
  • Mice, Knockout
  • Myocardial Reperfusion Injury* / enzymology
  • Myocardial Reperfusion Injury* / genetics
  • Myocardial Reperfusion Injury* / metabolism
  • Myocardial Reperfusion Injury* / pathology
  • Myocardial Reperfusion Injury* / prevention & control

Substances

  • Histone Deacetylase Inhibitors
  • Histone Deacetylase 6